Materias dentro de su búsqueda.
Mostrando 1,641 - 1,660 Resultados de 15,180 Para Buscar '"Hepatitis C"', tiempo de consulta: 0.37s Limitar resultados
  1. 1641
    “…BACKGROUND: The hepatitis C virus (HCV) NS5A inhibitor ABT-267 (ombitasvir, OBV), the HCV NS4/4A protease inhibitor ABT-450 (paritaprevir, PTV), the CYP3A inhibitor ritonavir (r) and the non-nucleoside NS5B polymerase inhibitor ABT-333 (dasabuvir, DSV) (OBV/PTV/r + DSV) with or without ribavirin (RBV) is a direct-acting antiviral regimen approved in the United States and other major countries for the treatment of HCV in genotype 1 (GT1) infected patients. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Ombitasvir/paritaprevir/ritonavir + dasabuvir +/- ribavirin in real world hepatitis C patients
  2. 1642
    “…Recently, Human Immunodeficiency Virus (HIV)/Hepatitis C (HCV) co-infected persons were reported to have an increased incidence of insulin resistance and lipodystrophy when compared to mono-infected persons. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SAT-136 Investigation of Glycemic State among Responders to Hepatitis C Treatment
  3. 1643
    “…BACKGROUND: Current guidelines do not address the post–sustained virological response management of patients with baseline hepatitis C virus (HCV) cirrhosis and oesophageal varices taking betablockers as primary or secondary prophylaxis of variceal bleeding. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Management of betablocked patients after sustained virological response in hepatitis C cirrhosis
  4. 1644
    por Sahin, Memduh, Yetim, Aylin, Ates, Fehmi
    Publicado 2019
    “…Hepatitis C virus is one of the leading causes of liver cirrhosis and hepatocellular carcinoma. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The role of tacstd-2 level in hepatitis C patients (controlled clinical research)
  5. 1645
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Liver sinusoidal endothelial cells (LSECs) modifications in patients with chronic hepatitis C
  6. 1646
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Retrospective Surveillance of Perinatal Hepatitis C Virus Exposure – Tennessee, 2013-2017
  7. 1647
    “…BACKGROUND: Age cohort screening for hepatitis C virus (HCV) might be an effective strategy if the majority of undiagnosed cases are concentrated in a particular age group. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Community screening for hepatitis C virus infection in a low-prevalence population
  8. 1648
    por Cotter, Thomas G, Jensen, Donald M
    Publicado 2019
    “…Direct-acting antiviral (DAA) therapy has changed the landscape of hepatitis C virus (HCV) management and has changed the focus to the possibility of HCV elimination in the near future. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Glecaprevir/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy
  9. 1649
    “…BACKGROUND: Hepatitis C affects about 3 % of the world’s population. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparing drug safety of hepatitis C therapies using post-market data
  10. 1650
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Correction: Chronic Hepatitis C: Conspectus of immunological events in the course of fibrosis evolution
  11. 1651
    “…AIM OF THE STUDY: Chronic hepatitis C (CHC) is a viral disease with metabolic disturbances involved in its pathogenesis. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Visfatin serum concentration and hepatic mRNA expression in chronic hepatitis C
  12. 1652
    “…This cross-sectional study assesses and compares the prevalence of hepatitis C virus among criminal justice populations in New Mexico, a state with high hepatitis C virus prevalence, and Georgia, a state with low hepatitis C virus prevalence.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Assessment and Comparison of Hepatitis C Viremia in the Prison Systems of New Mexico and Georgia
  13. 1653
    “…BACKGROUND: Transmission of human hepegivirus 1 (HHpgV-1), a novel human pegivirus, is closely associated with hepatitis C virus (HCV). The impact of HHpgV-1 viremia on HCV infection is unknown. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Epidemiological and Clinical Characteristics of Human Hepegivirus 1 Infection in Patients With Hepatitis C
  14. 1654
    “…Several such GWAS have highlighted the IFN-λ locus on chromosome 19q13 as an area of genetic variation significantly associated with hepatitis C virus (HCV) infection, and the rs12979860 genotype can be used in clinical practice as a biomarker for predicting a successful response to treatment with pegylated IFN and ribavarin. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The Role of Interferon-λ Locus Polymorphisms in Hepatitis C and Other Infectious Diseases
  15. 1655
    “…Repeat testing confirmed ongoing hepatitis C infection with increasing quantitative hepatitis C virus (HCV) levels. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Reactivation of Chronic Hepatitis C as a Potential Trigger for Guillain-Barré Syndrome
  16. 1656
    “…It has been estimated by the World Health Organization (WHO) that over 71 million people were infected with the hepatitis C virus (HCV) in 2015. Since then, a number of highly effective direct-acting antiviral (DAA) regimens have been licensed for the treatment of chronic HCV infection: sofosbuvir/daclatasvir, sofosbuvir/ledipasvir, elbasvir/grazoprevir, sofosbuvir/velpatasvir, glecaprevir/pibrentasvir, and sofosbuvir/velpatasvir/voxilaprevir. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update
  17. 1657
    “…OBJECTIVES/SPECIFIC AIMS: Hepatitis C virus (HCV) has a high prevalence among individuals in jail and prisons. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    3209 Hepatitis C Virus Linked To Increased Mortality in Inmates Who Are Hospitalized
  18. 1658
    “…Hepatitis C virus (HCV) triggers massive production of reactive oxygen species (ROS) and affects expression of genes encoding ROS-scavenging enzymes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Virus RNA-Dependent RNA Polymerase Is Regulated by Cysteine S-Glutathionylation
  19. 1659
    “…BACKGROUND: The hepatitis C virus (HCV) is known to infect the brain, however, the findings based on associated neuropsychiatric syndrome are controversial and the association itself remains unclear. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Hepatitis C Pretreatment Profile and Gender Differences: Cognition and Disease Severity Effects
  20. 1660
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    309. Should Primary Care Practitioners Follow Hepatitis C Exposed Infants?
Herramientas de búsqueda: RSS